GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Increasing market volatility will encourage high net worth investors to seek financial advice

Financial market volatility on the back of political and economic uncertainty on both sides of the Atlantic is driving uptake of financial advice in the high net worth (HNW) space. Investors are hunting for returns, and perhaps a little reassurance, in increasingly risky parts of financial markets, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

UK tablets and e-readers market will decline by 7.7% to 2022

Although the computers and tablets market in the UK is expected to experience substantial growth over the next few years, the tablets and e-readers market is expected to decline by 2022. This will be driven by mobile phones growing in size and 2-in-1 hybrids combining computers and tablets cannibalising trade from both markets, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Customization will spearhead beauty and grooming trends in 2017

Consumers are recognizing the importance of smarter and more connected beauty solutions. These are experiencing a major boom due to the need for tech-validation, alongside the growing desire for more customized beauty offerings that provide unique benefits to each individual consumer, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Viscosupplementation market in the Middle East and Africa to hit $37 million by 2023

The viscosupplementation space in the Middle East and Africa, which includes the five major markets of Egypt, Israel, Saudi Arabia, South Africa, and the United Arab Emirates, is set to grow from $23.3 million in 2016 to around $37 million by 2023, representing a compound annual growth rate (CAGR) of 4.9%, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Tauopathies market entry requires shrewd strategies from pharma companies

Pharmaceutical companies hoping to effectively compete in the tauopathies space, which is yet to see its first drug hit the market, are adopting a broad range of strategies including entering into licensing agreements and partnerships for the co-development of products, and pursuing multiple indications and drug candidates, according to GlobalData, a recognized leader in providing business information and analytics.
Read more
1 766 767 768 769